Balloon trick during cancer surgery may prevent stomach troubles
NCT ID NCT07355374
First seen Jan 23, 2026 · Last updated Jun 22, 2026 · Updated 16 times
Summary
This study tests whether inflating a small balloon in the pylorus (the valve between stomach and small intestine) during minimally invasive esophageal cancer surgery can prevent delayed stomach emptying, a common complication. About 116 patients will be randomly assigned to receive the balloon dilation or standard surgery alone. The main goal is to see if the procedure reduces stomach emptying problems within the first two weeks after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELAYED GASTRIC CONDUIT EMTPYING (DGCE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clarunis University Digestive Health Care Center Basel
RECRUITINGBasel, Canton of Basel-City, 4058, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
endoscopic pylorus balloon dilation
What this could lead to
If effective, this simple procedure could become a standard addition to esophagectomy, reducing complications and speeding recovery.
What could go wrong
This is a single-center trial with 116 patients, so results may not apply broadly. The procedure also carries rare risks like perforation or bleeding.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.